Optimum treatment for mediastinal lymph node positive (N2) resectable non-small cell lung cancer: What is the role for surgery?

about

Optimum treatment for mediastinal lymph node positive (N2) resectable non-small cell lung cancer: What is the role for surgery?

Item

http://www.wikidata.org/entity/Q38818969

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Optimum treatment for mediasti ...... What is the role for surgery?

@en

type

Item

label

Optimum treatment for mediasti ...... What is the role for surgery?

@en

prefLabel

Optimum treatment for mediasti ...... What is the role for surgery?

@en

P1476

Optimum treatment for mediasti ...... What is the role for surgery?

@en

P2093

Christopher W Towe

http://www.w3.org/2001/XMLSchema#string

Jimmy T Efird

http://www.w3.org/2001/XMLSchema#string

Musaddiq Awan

http://www.w3.org/2001/XMLSchema#string

Neelesh Sharma

http://www.w3.org/2001/XMLSchema#string

Tithi Biswas

http://www.w3.org/2001/XMLSchema#string

P2860

The role of chemotherapy in the management of stage IIIA non-small cell lung cancer

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.

Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer.

Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.

Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data

Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial

P31

scholarly article

P356

10.1080/14737140.2016.1240039

http://www.w3.org/2001/XMLSchema#string

P50

Mitchell Machtay

P577

2016-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27654059

http://www.w3.org/2001/XMLSchema#string